A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.
Previously, we have developed a retro-inverso peptide inhibitor (RI-OR2, rGffvlkGr) that blocks the in vitro formation and toxicity of the Aβ oligomers which are thought to be a cause of neurodegeneration and memory loss in Alzheimer's disease. We have now attached a retro-inverted version of t...
Guardado en:
Autores principales: | Vadivel Parthsarathy, Paula L McClean, Christian Hölscher, Mark Taylor, Claire Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini, David Allsop |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/491b10218dfe403ebcc52f614cb642ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Andrographolide promotes hippocampal neurogenesis and spatial memory in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease
por: Sebastian B. Arredondo, et al.
Publicado: (2021) -
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Maria Vincenza Carriero, et al.
Publicado: (2017) -
Genome-wide analysis of miRNA signature in the APPswe/PS1ΔE9 mouse model of alzheimer's disease.
por: Hongxue Luo, et al.
Publicado: (2014) -
nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse
por: D’Angelo Chiara, et al.
Publicado: (2021) -
Early β adrenoceptor dependent time window for fear memory persistence in APPswe/PS1dE9 mice
por: Smitha Karunakaran
Publicado: (2021)